Trial NCT02291055

View at ClinicalTrials.gov 
Org. Study IDs: ADXS001-04

Last trial update was posted on 2023-03-20

MeSH Interventions

Durvalumab

MeSH Conditions

Head and Neck Neoplasms

Other Conditions

Cancer Cervical Cancer Head and Neck Cancer

Stopping Reasons

N/A

Limitations And Caveats

Based on a discussion with the FDA, a 1-year duration of the Listeria monocytogenes surveillance period was considered sufficient (instead of protocol specified 3-years period) to monitor and characterize any potential risk associated with delayed listeremia, and therefore, the study was terminated early.

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID